General Information of the Compound
| Compound ID |
CP0892860
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-{4-[4-(3-Chlorophenyl)-piperazin-1-yl]-butyl}-6-quinolinesulfonamide hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H28Cl2N4O2S
|
||||||||||||||||||
| Molecular Weight |
495.476
|
||||||||||||||||||
| Canonical SMILES |
Cl.O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2)CC1)c1ccc2ncccc2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H27ClN4O2S.ClH/c24-20-6-3-7-21(18-20)28-15-13-27(14-16-28)12-2-1-11-26-31(29,30)22-8-9-23-19(17-22)5-4-10-25-23;/h3-10,17-18,26H,1-2,11-16H2;1H
Show/Hide
|
||||||||||||||||||
| InChIKey |
XNSALGTWJGHAFH-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7